Study of oxycodone with nafamostat in healthy adults
Treatments studied
This trial tests how a new combination of oxycodone and nafamostat works in the body. It is for healthy volunteers aged 18 to 55 to help understand the drug's safety and how it is processed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are generally healthy, with no serious medical conditions like heart, liver, kidney, or lung disease.
- You have not smoked or used nicotine products in the last year.
- You do not take most prescription or over-the-counter medications regularly, except for acetaminophen (Tylenol), hormone therapy, or hormonal birth control.
- You have no history of drug or alcohol abuse in the past 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new tablet in healthy adults to see how the body processes it and whether food changes its effects. It helps determine the right dose and safety for future patients.
This trial tests a new investigational drug called VK4-116 in healthy volunteers to see how food affects its absorption in the body. Participation may help researchers understand how the drug works and could lead to new treatments for conditions like opioid use disorder, though you would not directly benefit.
This study tests an investigational oral medication called MG001 in healthy people who have recently used oral opioids. It aims to see how the drug affects your body and whether it is safe.
This study looks at how the combination of gabapentin and oxycodone affects feelings of reward or abuse (like euphoria) in healthy people who have used opioids recreationally. It helps understand if this combination might be more or less abusable.
This study compares two forms of an experimental drug called vonafexor to see how they work in the body and if they interact with other medications. It's for healthy volunteers to make sure the drug is safe before testing in patients with liver disease.
This trial tests a new implant form of the medicine nalmefene to see if it is safe and well-tolerated in healthy adults. It is an early-phase study that helps researchers understand how the body reacts to the implant before testing it in people with opioid use problems.
Hear when a new Pharmacokinetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.